Treatment for lumbar spinal stenosis in elderly patients using percutaneous endoscopic lumbar discectomy combined with postoperative three-dimensional traction

Hu, Dexin; Fei, Jun; Chen, Genjun; Yu, Yongjie; Lai, Zhen

doi:10.1080/17434440.2019.1599282

“…Sixty patients were selected to assess the effect of compression therapy on posterior lumbar interbody fusion. For the convenience of comparability, factors affecting the incidence of wound complications post lumbar surgery, such as chronic steroid use and diabetes, were excluded [8,19,20] . To offset lumbar lordosis, the aseptic dressing was folded into a shuttle shape.…”

Section: Discussionmentioning

confidence: 99%

“…Patients ≤40 years of age or with other risk factors [8,19,20] were excluded from the study. Only patients aged >40 years exhibiting typical clinical symptoms of lumbar spinal stenosis, and radiological confirmation were included.…”

Section: Introductionmentioning

confidence: 99%

Compression Therapy Following Posterior Lumbar Interbody Fusion: A Prospective, Randomized, Clinical Study

Sun

¹

,

Gao

²

,

Zhu

³

et al. 2019

Preprint

0

View full text Add to dashboard Cite

Background: Wound-related complications are an inevitable issue faced by spinal surgeons. Negative pressure drainage remains the most commonly used method to prevent postoperative hematoma and related complications. This prospective, randomized, controlled study was conducted to evaluate the efficacy of compression therapy following posterior lumbar interbody fusion, with emphasis on pain, anemia, and inflammation. Methods: Sixty consecutive patients who have undergone posterior lumbar interbody fusion in the age range 43–78 years, with an average age of 59 years, were selected and randomly assigned into two groups. Factors, such as drainage volume, visual analog scale (VAS) pain score for back pain, white blood cell (WBC) count , red blood cell (RBC) count, hemoglobin (Hb) levels, erythrocyte sedimentation rate(ESR), and C-reactive protein (CRP) levels assessed on the 1st, 3rd, and 10th days postoperatively, were compared between the two groups. Results: The average follow-up was 6 months, ranging from 3 to 11 months. Drainage volume, VAS score, and CRP levels on the 10th day after the surgery were found to be significantly lower in the treatment group than in the control group. RBC count and Hb levels on the 3rd and 10th postoperative days were observed to be significantly higher in the treatment group than in the control group ( P <0.05). During discharge, the wounds of the patients of the both groups had healed and neither showed any symptoms of infection, hematoma, or necrosis. Conclusion: Compression therapy relieves pain, alleviates anemia, and the inflammatory response following posterior lumbar interbody fusion.

show abstract

“…Sixty patients were selected to assess the effect of compression therapy on posterior lumbar interbody fusion. For the convenience of comparability, factors affecting the incidence of wound complications post lumbar surgery, such as chronic steroid use and diabetes, were excluded [8,19,20] . To offset lumbar lordosis, the aseptic dressing was folded into a shuttle shape.…”

Section: Discussionmentioning

confidence: 99%

“…Patients ≤40 years of age or with other risk factors [8,19,20] were excluded from the study. Only patients aged >40 years exhibiting typical clinical symptoms of lumbar spinal stenosis, and radiological confirmation were included.…”

Section: Introductionmentioning

confidence: 99%

Compression Therapy Following Posterior Lumbar Interbody Fusion: A Prospective, Randomized, Clinical Study

Sun

¹

,

Gao

²

,

Zhu

³

et al. 2019

Preprint

0

View full text Add to dashboard Cite

Background: Wound-related complications are an inevitable issue faced by spinal surgeons. Negative pressure drainage remains the most commonly used method to prevent postoperative hematoma and related complications. This prospective, randomized, controlled study was conducted to evaluate the efficacy of compression therapy following posterior lumbar interbody fusion, with emphasis on pain, anemia, and inflammation. Methods: Sixty consecutive patients who have undergone posterior lumbar interbody fusion in the age range 43–78 years, with an average age of 59 years, were selected and randomly assigned into two groups. Factors, such as drainage volume, visual analog scale (VAS) pain score for back pain, white blood cell (WBC) count , red blood cell (RBC) count, hemoglobin (Hb) levels, erythrocyte sedimentation rate(ESR), and C-reactive protein (CRP) levels assessed on the 1st, 3rd, and 10th days postoperatively, were compared between the two groups. Results: The average follow-up was 6 months, ranging from 3 to 11 months. Drainage volume, VAS score, and CRP levels on the 10th day after the surgery were found to be significantly lower in the treatment group than in the control group. RBC count and Hb levels on the 3rd and 10th postoperative days were observed to be significantly higher in the treatment group than in the control group ( P <0.05). During discharge, the wounds of the patients of the both groups had healed and neither showed any symptoms of infection, hematoma, or necrosis. Conclusion: Compression therapy relieves pain, alleviates anemia, and the inflammatory response following posterior lumbar interbody fusion.

show abstract

“…Patients ≤40 years of age or with other risk factors [8, 19, 20] were excluded from the study. Only patients aged > 40 years exhibiting typical clinical symptoms of lumbar spinal stenosis, and radiological confirmation were included.…”

Section: Methodsmentioning

confidence: 99%

Compression therapy following posterior lumbar interbody fusion: a prospective, randomized, clinical study

Sun

¹

,

Gao

²

,

Zhu

³

et al. 2019

BMC Surg

0

View full text Add to dashboard Cite

BackgroundWound-related complications are an inevitable issue faced by spinal surgeons. Negative pressure drainage remains the most commonly used method to prevent postoperative hematoma and related complications. This prospective, randomized, controlled study was conducted to evaluate the efficacy of compression therapy following posterior lumbar interbody fusion, with emphasis on pain, anemia, and inflammation.MethodsSixty consecutive patients who have undergone posterior lumbar interbody fusion in the age range 43–78 years, with an average age of 59 years, were selected and randomly assigned into two groups. Factors, such as drainage volume, visual analog scale (VAS) pain score for back pain, white blood cell (WBC) count, red blood cell (RBC) count, hemoglobin (Hb) levels, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels assessed on the 1st, 3rd, and 10th days postoperatively, were compared between the two groups.ResultsThe average follow-up was 6 months, ranging from 3 to 11 months. Drainage volume, VAS score, and CRP levels on the 10th day after the surgery were found to be significantly lower in the treatment group than in the control group. RBC count and Hb levels on the 3rd and 10th postoperative days were observed to be significantly higher in the treatment group than in the control group (P < 0.05). During discharge, the wounds of the patients of the both groups had healed and neither showed any symptoms of infection, hematoma, or necrosis.ConclusionCompression therapy relieves pain, alleviates anemia, and the inflammatory response following posterior lumbar interbody fusion.Trial registrationChiCTR1800015825 on chictr.org.cn, April 23, 2018, the trial registry is Chinese Clinical Trial Registry.

show abstract

Treatment for lumbar spinal stenosis in elderly patients using percutaneous endoscopic lumbar discectomy combined with postoperative three-dimensional traction

Cited by 19 publications

References 21 publications

Compression Therapy Following Posterior Lumbar Interbody Fusion: A Prospective, Randomized, Clinical Study

Compression Therapy Following Posterior Lumbar Interbody Fusion: A Prospective, Randomized, Clinical Study

Compression Therapy Following Posterior Lumbar Interbody Fusion: A Prospective, Randomized, Clinical Study

Compression therapy following posterior lumbar interbody fusion: a prospective, randomized, clinical study

Contact Info

Product

Resources

About